Chen Hong-Jin, Huang Ting-Xiong, Jiang Yu-Xi, Chen Xiong, Wang Ai-Fang
Department of Pharmacology, School of Basic Medical Sciences, Translational Medicine Research Center, Guizhou Medical University, Guiyang 550025, Guizhou Province, China.
School of Clinical Medical, Translational Medicine Research Center, Guizhou Medical University, Guiyang 550025, Guizhou Province, China.
World J Hepatol. 2023 Dec 27;15(12):1258-1271. doi: 10.4254/wjh.v15.i12.1258.
Primary liver cancer is a severe and complex disease, leading to 800000 global deaths annually. Emerging evidence suggests that inflammation is one of the critical factors in the development of hepatocellular carcinoma (HCC). Patients with viral hepatitis, alcoholic hepatitis, and steatohepatitis symptoms are at higher risk of developing HCC. However, not all inflammatory factors have a pathogenic function in HCC development. The current study describes the process and mechanism of hepatitis development and its progression to HCC, particularly focusing on viral hepatitis, alcoholic hepatitis, and steatohepatitis. Furthermore, the roles of some essential inflammatory cytokines in HCC progression are described in addition to a summary of future research directions.
原发性肝癌是一种严重且复杂的疾病,每年在全球导致80万人死亡。新出现的证据表明,炎症是肝细胞癌(HCC)发生发展的关键因素之一。患有病毒性肝炎、酒精性肝炎和脂肪性肝炎症状的患者患HCC的风险更高。然而,并非所有炎症因子在HCC发生发展中都具有致病作用。本研究描述了肝炎发生发展及其进展为HCC的过程和机制,特别关注病毒性肝炎、酒精性肝炎和脂肪性肝炎。此外,除了总结未来的研究方向外,还描述了一些重要炎症细胞因子在HCC进展中的作用。
Metabolism. 2016-8
Front Oncol. 2020-11-30
Biochim Biophys Acta Mol Basis Dis. 2017-11-29
Cancer Immunol Immunother. 2025-6-7
Clin Med Insights Oncol. 2023-4-7
Cancers (Basel). 2022-12-7
J Cancer Res Clin Oncol. 2023-7